Studies have shown that Xist is highly expressed in certain tumors, such as glioblastoma [19], breast cancer [20] and ovarian cancer [21], indicating that Xist can be used as a biomarker for the diagnosis of neoplastic diseases. Here, XIST is linked to ovarian carcinoma.